Just read the PR for the second time. It is clear we are no longer in the realm of wait and see and hope someone notices us. It's all systems go, with the US government fully on board and helping. Phase III in late summer! Plan already set up and in place for mass dissemination if the trial is successful! EUA approval already lined up! Manufacturing lined up! Canada lining up!
This is all pretty incredibly good news. To me, this sounds like NGIO is not just one of the herd of potential vaccine companies anymore, but is at the forefront and is getting much attention and help from the powers that be.
Only reason pps is not much higher is we just haven't been discovered by the masses yet.
(4)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links